HIGHLIGHTS
- who: Kirsten A. Berk from the This study includes two independent trialsTrial , is a two-armed non-randomized study which compared the, year effects of RYGB (surgery-group) with intensive lifestyle intervention (lifestyle-group) (Clinicaltrials.gov NCT00626964), conducted at the Morbid Obesity Centre, Vestfold Hospital Trust, Tnsberg, Norway between February , and February, . Inclusion criteria were BMI u2265 , kg/m2, or u2265 , kg/m, and at least one obesity related comorbidity. The primary outcome (arterial stiffness) and data on weight-loss and changes in metabolic biomarkers have previously been published [20, ]. Trial , includes individuals who participated in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.